These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22235796)

  • 21. Expression of iNOS, COX-2 and VEGF in canine mammary tumours and non-neoplastic mammary glands: Association with clinicopathological features and tumour grade.
    Anadol E; Yar Saglam AS; Gultiken N; Karakas K; Alcigir E; Alkan H; Kanca H
    Acta Vet Hung; 2017 Sep; 65(3):382-393. PubMed ID: 28956485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Receptors for oestrogen, progesterone and epidermal growth factor in normal and tumorous canine mammary tissues.
    Donnay I; Rauïs J; Wouters-Ballman P; Devleeschouwer N; Leclercq G; Verstegen JP
    J Reprod Fertil Suppl; 1993; 47():501-12. PubMed ID: 8229969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CA15.3, CEA and LDH in dogs with malignant mammary tumors.
    Campos LC; Lavalle GE; Estrela-Lima A; Melgaço de Faria JC; Guimarães JE; Dutra ÁP; Ferreira E; de Sousa LP; Rabelo ÉM; Vieira da Costa AF; Cassali GD
    J Vet Intern Med; 2012; 26(6):1383-8. PubMed ID: 23113715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A non-radiometric method for measuring serum thymidine kinase activity in malignant lymphoma in dogs.
    von Euler HP; Ohrvik AB; Eriksson SK
    Res Vet Sci; 2006 Feb; 80(1):17-24. PubMed ID: 16140350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantification of VEGF-C expression in canine mammary tumours.
    Qiu C; Lin DD; Wang HH; Qiao CH; Wang J; Zhang T
    Aust Vet J; 2008 Jul; 86(7):279-82. PubMed ID: 18616481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Total serum alkaline phosphatase activity in dogs with mammary neoplasms: a prospective study on 79 natural cases.
    Karayannopoulou M; Koutinas AF; Polizopoulou ZS; Roubies N; Fytianou A; Saridomichelakis MN; Kaldrymidou E
    J Vet Med A Physiol Pathol Clin Med; 2003 Dec; 50(10):501-5. PubMed ID: 15157017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical detection of progesterone and cellular proliferation in canine mammary tumours.
    Thuróczy J; Reisvaag GJ; Perge E; Tibold A; Szilágyi J; Balogh L
    J Comp Pathol; 2007; 137(2-3):122-9. PubMed ID: 17645888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Population-based incidence of mammary tumours in some dog breeds.
    Moe L
    J Reprod Fertil Suppl; 2001; 57():439-43. PubMed ID: 11787188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Canine mammary gland tumours; a histological continuum from benign to malignant; clinical and histopathological evidence.
    Sorenmo KU; Kristiansen VM; Cofone MA; Shofer FS; Breen AM; Langeland M; Mongil CM; Grondahl AM; Teige J; Goldschmidt MH
    Vet Comp Oncol; 2009 Sep; 7(3):162-72. PubMed ID: 19691645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COX-2 over-expression correlates with VEGF and tumour angiogenesis in canine mammary cancer.
    Queiroga FL; Pires I; Parente M; Gregório H; Lopes CS
    Vet J; 2011 Jul; 189(1):77-82. PubMed ID: 20675158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proliferative activity, apoptosis and expression of oestrogen receptor and Bcl-2 oncoprotein in canine mammary gland tumours.
    Yang WY; Liu CH; Chang CJ; Lee CC; Chang KJ; Lin CT
    J Comp Pathol; 2006 Jan; 134(1):70-9. PubMed ID: 16423573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fine-needle aspiration biopsy of canine mammary gland tumours: a comparison between cytology and histopathology.
    Sontas BH; Yüzbaşıoğlu Öztürk G; Toydemir TF; Arun SS; Ekici H
    Reprod Domest Anim; 2012 Feb; 47(1):125-30. PubMed ID: 21615802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxidative stress parameters in bitches with mammary gland tumours.
    Szczubiał M; Kankofer M; Łopuszyński W; Dabrowski R; Lipko J
    J Vet Med A Physiol Pathol Clin Med; 2004; 51(7-8):336-40. PubMed ID: 15533114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of Cox-1 and Cox-2 in canine mammary tumours.
    Queiroga FL; Alves A; Pires I; Lopes C
    J Comp Pathol; 2007; 136(2-3):177-85. PubMed ID: 17416236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical expression of caveolin-1 in normal and neoplastic canine mammary tissue.
    Amorim I; Lopes CC; Faustino AM; Pereira PD
    J Comp Pathol; 2010 Jul; 143(1):39-44. PubMed ID: 20153867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on canine mammary tumours. II. Oestradiol and progesterone receptor binding capacity and histological type.
    Boldizsár H; Muray T; Számel I; Szenci O; Csenki J
    Acta Vet Hung; 1992; 40(1-2):89-97. PubMed ID: 1476094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metallothionein expression in benign and malignant canine mammary gland tumours.
    Erginsoy SD; Sozmen M; Caldin M; Furlanello T
    Res Vet Sci; 2006 Aug; 81(1):46-50. PubMed ID: 16289156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Steroids and receptors in canine mammary cancer.
    Illera JC; Pérez-Alenza MD; Nieto A; Jiménez MA; Silvan G; Dunner S; Peña L
    Steroids; 2006 Jul; 71(7):541-8. PubMed ID: 16631217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum Galectin-3 Levels in Dogs with Metastatic and Non-metastatic Mammary Tumors.
    Ribeiro C; Santos MS; DE Matos AJ; Barros R; Gärtner F; Rutteman GR; DE Oliveira JT
    In Vivo; 2016; 30(1):13-6. PubMed ID: 26709123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolactin--to be reconsidered in canine mammary tumourigenesis?
    Michel E; Rohrer Bley C; Kowalewski MP; Feldmann SK; Reichler IM
    Vet Comp Oncol; 2014 Jun; 12(2):93-105. PubMed ID: 22738741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.